Your browser doesn't support javascript.
loading
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.
Santoni, Matteo; Massari, Francesco; Takeshita, Hideki; Tapia, Jose Carlos; Dionese, Michele; Pichler, Renate; Rizzo, Mimma; Lam, Elaine T; Grande, Enrique; Kemp, Robert; Molina-Cerrillo, Javier; Calabrò, Fabio; Tural, Deniz; Küronya, Zsófia; Kucharz, Jakub; Fiala, Ondrej; Seront, Emmanuel; Kopp, Ray Manneh; Abahssain, Halima; Kopecky, Jindrich; Martignetti, Angelo; Kanesvaran, Ravindran; Zakopoulou, Roubini; Ansari, Jawaher; Landmesser, Johannes; Mollica, Veronica; Porta, Camillo; Bellmunt, Joaquim; Salah, Samer; Santini, Daniele.
Afiliação
  • Santoni M; Oncology Unit, Macerata Hospital, via Santa Lucia 2, 62100, Macerata, Italy.
  • Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italy.
  • Takeshita H; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Tapia JC; Department of Medical Oncology, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creui Sant Pau, Barcelona, Spain.
  • Dionese M; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, 35128, Padua, Italy.
  • Pichler R; Department of Urology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
  • Rizzo M; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.
  • Lam ET; University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Kemp R; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.
  • Calabrò F; Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Tural D; Department of Medical Oncology, Bakirköy Dr.SadiKonuk Training and Research Hospital, Zuhuratbaba District, TevfikSaglam St. No: 11, Bakirkoy, Istanbul, Turkey.
  • Küronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary.
  • Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Seront E; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, alejSvobody 76, Pilsen, Czech Republic.
  • Kopp RM; Department of Medical Oncology, Centre Hospitalier de Jolimont, Haine Saint Paul, La Louvière, Belgium.
  • Abahssain H; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia.
  • Kopecky J; Medicine and Pharmacy Faculty, National Institute of Oncology, Medical Oncology Unit, Mohamed V University, Rabat, Morocco.
  • Martignetti A; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Kanesvaran R; Dipartimento oncologico usl sud-est toscana-area senese, Località Campostaggia s.n.c., 53036, Poggibonsi, Italy.
  • Zakopoulou R; National Cancer Centre Singapore, Singapore, Singapore.
  • Ansari J; 2nd Propaedeutic Department of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Landmesser J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates.
  • Mollica V; Klinik fürUrologie, Ratzeburger Allee 160, 23538, Lübeck, Germany.
  • Porta C; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italy. veronica.mollica7@gmail.com.
  • Bellmunt J; Chair of Oncology, Interdisciplinary Department of Medicine, University of Bari "Aldo Moro", Bari, Italy.
  • Salah S; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Santini D; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Clin Exp Med ; 23(8): 5413-5422, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37917218
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Neoplasias Ósseas / Carcinoma de Células de Transição / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Revista: Clin Exp Med Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Neoplasias Ósseas / Carcinoma de Células de Transição / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Revista: Clin Exp Med Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália